CCG
INSM icon

Capital CS Group’s Insmed INSM Stock Holding History

Capital CS Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,488
Closed -$586K – 78
2024
Q4 		$586K Buy
+8,488
New +$611K 0.77% 24

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Capital CS Group's INSM Position: Q1 2025 in Review

Capital CS Group sold out of Insmed (INSM) in Q1 2025, closing a stake of 8,488 shares — an estimated $586K sold.

Capital CS Group first reported a position in INSM in Q4 2024 and held it in 1 quarter. The position peaked at $586K in Q4 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

  • Capital CS Group reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
  • Capital CS Group sold 8,488 Insmed shares in Q1 2025, an estimated $586K.
  • Capital CS Group first reported a position in Insmed in Q4 2024 and held it in 1 quarter.
  • Capital CS Group's Insmed position peaked at $586K in Q4 2024.
  • 441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Capital CS Group's 13F filing for Q1 2025, filed 9 Apr 2025.